Potassium and magnesium deficiency, its role in cardiovascular disease development and possibilities of correction
- Authors: Baryshnikova G.A.1, Chorbinskaya S.A.1, Stepanova I.I.1, Blokhina O.E.1
-
Affiliations:
- Central State Medical Academy of the President
- Issue: Vol 21, No 1 (2019)
- Pages: 67-73
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/96896
- DOI: https://doi.org/10.26442/20751753.2019.1.190240
- ID: 96896
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Galina A. Baryshnikova
Central State Medical Academy of the President
Email: bargalan@mail.ru
D. Sci. (Med.), Prof. at Department of Family Medicine with Course of Clinical Laboratory Medicine, Psychiatry, and Behavioral Therapy 19, Timoshenko st., Moscow, 121359, Russian Federation
Svetlana A. Chorbinskaya
Central State Medical Academy of the PresidentD. Sci. (Med.), Prof., Head of Department of Family Medicine with Course of Clinical Laboratory Medicine, Psychiatry, and Behavioral Therapy 19, Timoshenko st., Moscow, 121359, Russian Federation
Irina I. Stepanova
Central State Medical Academy of the PresidentCand. Sci. (Med.), Assistant Professor at Department of Family Medicine with Course of Clinical Laboratory Medicine, Psychiatry, and Behavioral Therapy 19, Timoshenko st., Moscow, 121359, Russian Federation
Olga E. Blokhina
Central State Medical Academy of the PresidentTeaching Assistant at Department of Family Medicine with Course of Clinical Laboratory Medicine, Psychiatry, and Behavioral Therapy 19, Timoshenko st., Moscow, 121359, Russian Federation
References
- Capewell S, Ford E.S, Croft J.B et al. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ 2010; 88 (2): 120-30.
- Weglicki W.B, Mak I.T, Chmielinska J.J et al. The role of magnesium deficiency in cardiovascular and intestinal inflammation. Magnes Res 2010.
- Fox C.H, Mahoney M.C, Ramsoomair D, Carter C.A. Magnesium deficiency in African-Americans: does it contribute to increased cardiovascular risk factors? J Natl Med Assoc 2003; 95 (4): 257-62.
- Lücker P.W, Witzmann H.K. Influence of magnesium and potassium deficiency on renal elimination and cardiovascular function demonstrated by impedance cardiography. Magnesium 1984; 3 (4-6): 265-73.
- Altura B.M, Shah N.C, Jiang X.C et al. Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. Am J Physiol Heart Circ Physiol 2009; 297 (1): H86-92.
- Shivakumar K. Pro-fibrogenic effects of magnesium deficiency in the cardiovascular system. Magnes Res 2002; 15 (3-4): 307-15.
- Abbrecht P.H. Cardiovascular effects of chronic potassium deficiency in the dog. Am J Physiol 1972; 223 (3): 555-60.
- Агаджанян Н.А., Тель Л.З., Циркин В.И., Чеснокова С.А. Физиология человека. СПб., 1998.
- Hoshino K, Ogawa K, Hishitani T et al. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int 2006; 48 (2): 112-7.
- He F, MacGregor G. Potassium intake and blood pressure. Am J Hypertens 1999; 12: 849-51.
- Шилов А.М., Мельник М.В., Осия А.О. и др. Лечение сердечно-сосудистых заболеваний в практике врача первичного звена здравоохранения: место препаратов калия и магния (Панангин). РМЖ. 2012; 3: 102-7.
- Булдакова Н.Г. Дефицит калия и магния при сердечно-сосудистых заболеваниях и методы его коррекции. РМЖ. 2008; 29: 1956-8
- Ухолкина Г.Б. Роль магния в заболеваниях сердечно-сосудистой системы. РМЖ. 2011; 7: 476-80.
- Gu D, He J, Xigui W et al. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo controlled trial. J Hypertens 2001; 19: 1325-31.
- D’Elia L, Barba G, Cappuccio F.P, Strazzullo P. Potassium intake,stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1210-9.
- Cohen H.W, Madhavan S, Alderman M.H. High and low serum potassium associated with cardiovascular events in diuretic-treated patients. J Hypertens 2001; 19 (7): 1315-23.
- Sica D.A, Struthers A.D, Cushman W.C. Importance of potassium in cardiovascular disease. J Clin Hypertens (Greenwich) 2002; 4 (3): 198-206.
- Yang Q, Liu T, Kuklina E.V et al. Sodium and potassium intake and mortality among US adults: prospective data from the third national health and nutrition examination survey. Arch Intern Med 2011; 171: 1183-91.
- Cappucio F, McGregor G. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 1991; 9: 456-73.
- Canadian Hypertension Education Program Guidelines for pressure Measurement, Diagnosis, Assessment of Risk, prevention and Treatment of Hypertension. Canadian J Cardiol 2016; 32: 569-88.
- Houston M.C. The importance of potassium in managing hypertension. Curr Hypertens Rep 2011; 13: 309-17.
- Громова О.А., Торшин И.Ю., Юдина Н.В. и др. Дефицит магния и нарушения регуляции тонуса сосудов. Кардиология. 2014; 7: 66-72.
- Kircelli F, Peter M.E, Ok E.S et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012; 27 (2): 514-21.
- Jee S.H, Miller E.R, Guallar E et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15: 691-6.
- Povoroznyuk V.V, Snezhitskiy V.A, Yankouskaya L.V et al. Extraskeletal effects of vitamin D: role in the pathogenesis of cardiovascular diseases. J Grodno State Med University 2015; 2 (50): 6-15.
- Gröber U, Schmidt J, Kisters K. Magnesium in Prevention and Therapy. Nutrients 2015; 7 (9): 8199-226.
- Corretti M.C, Anderson T.J, Benjamin E.J. et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol 2002; 39: 257-65.
- Shechter M. Magnesium and cardiovascular system. Magnes Res 2010; 23: 60-72.
- Del Gobbo L.C, Imamura F, Wu J.H et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013; 98: 160-73.
- Скальный А.В. Химические элементы в физиологии и экологии человека. М., 2004.
- Quantative Factors Regarding Magnesium Status in the Modern-Day World. Magnesium 1982; 1: 3-15.
- Громова O.A., Никонов A.A. Роль и значение магния в патогенезе заболеваний нервной системы. Журн. неврологии и психиатрии им. С.С.Корсакова. 2002; 2: 45-9.
- Ma B, Lawson A.B, Liese A.D et al. Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 2006; 164 (5): 449-58.
- Xuexian Fang, Kai Wang, Dan Han et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Medicine 2016; 14.1: 210.
- Whang R, Ryder K.W. Frequency of hypomagnesemia and hypermagnesemia: Requested vs routine. JAMA 1990; 263: 3063-4.
- Ascherio A, Rimm E, Hernan M. Intake of potassium, magnesium, calcium and fiber and risk of stroke among US men. Circulation 1998; 98: 1198-204.
- Костюченко Л.Н. Нарушения калий-магниевого гомеостаза и его коррекция в ходе нутриционной поддержки больных гастроэнтерологического профиля. Трудный пациент. 2010; 10: 14-8.
- Gröber U. Magnesium. In Micronutrients: Metabolic Tuning-Prevention-Therapy, 1st ed. Stuttgart, Germany: MedPharm Scientific Publishers, 2009; p. 159-66.
- Elin R.J. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010; 23: 194-8.
- Cohn J.N, Kowey P.R, Whelton P.K, Prisant L.M. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med 2000; 160 (16): 2429-36.
- Низовцева О.А. Комплексная терапия сердечно-сосудистых заболеваний и дефицит магния. Трудный пациент. 2014; 7: 37-41.
- Hациональные рекомендации по определению риска и профилактике внезапной сердечной смерти. Под ред. Е.В.Шляхто, Ю.Н.Беленковой. 2-е изд. М., 2018.
- Zola-Sleczek E, Mochalski W. Potassium magnesium aspartate (K-Mg-aspartate) in the treatment of digitalis glycoside poisoning. Folia Med Cracov 1979; 21 (2): 323-31.
- Whang R, Whang D, Ryan M. Arch Intern Med 1992; 152: 40-5.
- Биологическая химия с упражнениями и задачами. Под ред. С.Е.Северина. 3-е изд. М.: ГЭОТАР-Медиа, 2016.
- Xu Fengmei Jia Jizhen Yang Suhong. Effect of Panangin on left ventricular function in patients with coronary heart disease. J Kaifeng Med College 2000; 19 (3).
- Zhi Y.F et al. Clinical investigation of the protective effects of potassium magnesium aspartate against arrhythmia and its possible anti-oxidative mechanism. Chin Crit Care Med 2007; 19 (11): 662-6.
- Zhang Xing-Ping. Clinical observation of potassium magnesium aspartate in the treatment of angina pectoris of coronary heart disease. Chongqing Med J 2003; 32.
- Wang Huiqing, Wei Qida. Panangin's Effect on Unstable Angina Pectoris. J Tianjin Med University 1999; 5 (3).
- Tian Guoping, Yan Xibin. Therapeutic effect of potassium magnesium aspartate on heart failure. J Hengyang Med College 2000; 28 (4).
- Ляшенко Е.А. Роль калия и магния в профилактике инсульта. РМЖ. 2012; 19: 60-5.
- Агеев Ф.Т., Смирнова М.Д., Галанинский П.В. и др. Применение препарата Панангин в амбулаторной практике у больных артериальной гипертонией в период летней жары. Врач. 2012; 5: 64-9.
- Hak A.E, Pols H.A, Visser T.J et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med 2000; 132 (4): 270-8.
- Cappuccio F.P, Buchanan L.A, Ji C et al. Systematic review and meta-analysis of randomized controlled trials on the effects of potassium supplements on serum potassium and creatinine. BMJ Open 2016; 6: e011716. DOI: 10.1136
- Weir M.R, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol 2010; 5 (3): 531-48.